Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.07B | 1.80B | 1.96B | 2.91B | 2.16B | 1.95B |
Gross Profit | 831.69M | 696.47M | 610.48M | 595.16M | 438.04M | 370.81M |
EBITDA | 851.96M | 666.35M | 594.06M | 565.01M | 433.52M | 370.36M |
Net Income | 415.16M | 289.77M | 264.72M | 274.92M | 201.10M | 163.01M |
Balance Sheet | ||||||
Total Assets | 7.27B | 6.98B | 6.54B | 6.26B | 5.72B | 5.32B |
Cash, Cash Equivalents and Short-Term Investments | 83.71M | 1.02M | 954.00K | 1.11M | 4.75M | 117.01M |
Total Debt | 3.41B | 3.52B | 3.29B | 3.13B | 2.76B | 2.51B |
Total Liabilities | 4.79B | 4.78B | 4.55B | 4.44B | 4.09B | 3.67B |
Stockholders Equity | 2.48B | 2.20B | 1.99B | 1.82B | 1.63B | 1.64B |
Cash Flow | ||||||
Free Cash Flow | -99.03M | -143.91M | -61.93M | -274.95M | -233.66M | -256.69M |
Operating Cash Flow | 502.88M | 427.41M | 478.99M | 323.48M | 390.95M | 213.48M |
Investing Cash Flow | -486.27M | -569.07M | -538.63M | -590.61M | -622.12M | -994.02M |
Financing Cash Flow | 62.34M | 141.76M | 59.70M | 262.54M | 117.78M | 895.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $4.76B | 11.55 | 18.03% | 3.85% | 21.88% | 71.35% | |
71 Outperform | 4.65B | 17.03 | 8.21% | 3.99% | -6.65% | 11.47% | |
70 Outperform | 3.10B | 23.46 | 8.60% | 2.01% | 19.02% | 20.13% | |
68 Neutral | 4.70B | 18.68 | 7.78% | 3.44% | 13.43% | 6.49% | |
67 Neutral | 5.71B | 29.54 | 5.27% | 3.18% | -10.07% | 5.98% | |
61 Neutral | 7.06B | 17.31 | 8.58% | 4.60% | -0.52% | -39.42% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |
On September 10, 2025, New Jersey Resources announced the election of Amy B. Mansue to its Board of Directors, effective November 1, 2025, expanding the board from eleven to twelve members. Mansue, currently the President and CEO of Inspira Health Network, brings extensive experience from both the public and private sectors, which is expected to strengthen NJR’s strategic positioning and contribute to delivering long-term value for shareholders and customers.
The most recent analyst rating on (NJR) stock is a Buy with a $53.00 price target. To see the full list of analyst forecasts on New Jersey Resources stock, see the NJR Stock Forecast page.
On August 21, 2025, NJNG entered into a Note Purchase Agreement with institutional investors, selling $200 million in senior notes to fund general corporate purposes, including refinancing debt and capital expenditures. These notes, secured by NJNG’s First Mortgage Bonds, reflect a strategic financial maneuver to bolster the company’s operational capabilities and maintain financial flexibility, while adhering to certain covenants and restrictions.
The most recent analyst rating on (NJR) stock is a Buy with a $52.00 price target. To see the full list of analyst forecasts on New Jersey Resources stock, see the NJR Stock Forecast page.
On August 4, 2025, New Jersey Resources reported its fiscal 2025 third-quarter results, revealing a consolidated net loss of $15.1 million compared to a $11.6 million loss in the same quarter of 2024. However, the company showed improvement in its net financial earnings, reporting $6.2 million in the third quarter of 2025, up from a loss of $8.9 million in the previous year. Year-to-date net income also increased significantly to $320.6 million from $198.6 million in 2024. The company raised the lower end of its fiscal 2025 net financial earnings per share guidance, reflecting strong operational resilience and the impact of a diversified business model. This adjustment underscores NJR’s confidence in achieving its long-term growth targets and delivering consistent performance for its shareholders.
The most recent analyst rating on (NJR) stock is a Hold with a $53.00 price target. To see the full list of analyst forecasts on New Jersey Resources stock, see the NJR Stock Forecast page.